Dr. Hoffman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1611 NW 12th Ave
Miami, FL 33136Phone+1 305-243-4664Fax+1 305-243-9161
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2006 - 2009
NYU Grossman School of MedicineResidency, Internal Medicine, 2002 - 2006
Albert Einstein College of MedicineClass of 2002
Certifications & Licensure
FL State Medical License 2009 - 2027
NY State Medical License 2004 - 2012- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- Phase II Study to Evaluate Fenofibrate Therapy in Patients With Smoldering or Symptomatic Multiple Myeloma Start of enrollment: 2012 Nov 19
- Carpal Tunnel/Amyloidosis Blood Sample Study Start of enrollment: 2016 Feb 24
- A Safety Study of SEA-BCMA in Patients With Multiple Myeloma Start of enrollment: 2018 Nov 01
Publications & Presentations
PubMed
- From MGUS to multiple myeloma: Unraveling the unknown of precursor states.Gil Hevroni, Mounika Vattigunta, Dickran Kazandjian, David Coffey, Benjamin Diamond
Blood Reviews. 2024-11-01 - 8 citationsLinvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma.Naresh Bumma, Joshua Richter, Sundar Jagannath, Hans C Lee, James E Hoffman
Journal of Clinical Oncology. 2024-08-01 - 1 citationsMinimal Residual Disease-Adapted Therapy in Multiple Myeloma: Current Evidence and Opinions.Mina Meseha, James Hoffman, Dickran Kazandjian, Ola Landgren, Benjamin Diamond
Current Oncology Reports. 2024-06-01
Abstracts/Posters
- Hypogammaglobulinemia and Its Implications in Patients Treated with Daratumumab: A Single Institution ExperienceJames E. Hoffman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Response to Therapy and the Effectiveness of Treatment with Selinexor and Dexamethasone in Patients with Penta-Exposed Triple-Class Refractory Myeloma Who Had Plasmacy...James E. Hoffman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Hypogammaglobulinemia and Its Implications in Patients Treated with Daratumumab: A Single Institution ExperienceJames E. Hoffman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Press Mentions
Sylvester Cancer Tip Sheet: Researchers Present Posters at the 66th ASH Annual Meeting & ExpositionNovember 13th, 2024- Sylvester Pursues Landmark Research Presented at International Hematology ConferenceJanuary 30th, 2023
OncLive® Presents State of the Science Summit™ on Hematologic MalignanciesMarch 5th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
